par Bergh, Jonas;Mariani, Gabriella;Cardoso, Fatima ;Liljegren, A.;Awada, Ahmad ;Vigano, L.;Huang, Xing ;Verkh, L.;Kern, Kenneth A;Giorgetti, C.;Gianni, Luca
Référence Breast, 21, 4, page (507-513)
Publication Publié, 2012-08
Référence Breast, 21, 4, page (507-513)
Publication Publié, 2012-08
Article révisé par les pairs
Titre: |
|
Auteur: | Bergh, Jonas; Mariani, Gabriella; Cardoso, Fatima; Liljegren, A.; Awada, Ahmad; Vigano, L.; Huang, Xing; Verkh, L.; Kern, Kenneth A; Giorgetti, C.; Gianni, Luca |
Informations sur la publication: | Breast, 21, 4, page (507-513) |
Statut de publication: | Publié, 2012-08 |
Sujet CREF: | Cancérologie |
Mots-clés: | Advanced breast cancer |
Docetaxel | |
Sunitinib | |
Tyrosine kinase inhibitor | |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Agents -- administration & dosage -- adverse effects -- pharmacokinetics | |
Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics -- therapeutic use | |
Breast Neoplasms -- drug therapy -- metabolism | |
Carcinoma, Ductal, Breast -- drug therapy -- metabolism | |
Carcinoma, Lobular -- drug therapy -- metabolism | |
Drug Administration Schedule | |
Drug Interactions | |
Feasibility Studies | |
Female | |
Humans | |
Indoles -- administration & dosage -- adverse effects -- pharmacokinetics | |
Middle Aged | |
Neoplasm Recurrence, Local -- drug therapy | |
Pyrroles -- administration & dosage -- adverse effects -- pharmacokinetics | |
Receptor, erbB-2 -- metabolism | |
Taxoids -- administration & dosage -- adverse effects -- pharmacokinetics | |
Treatment Outcome | |
Note générale: | Clinical Trial |
Journal Article | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0960-9776 |
info:doi/10.1016/j.breast.2012.01.012 | |
info:pii/S0960-9776(12)00018-5 | |
info:scp/84863874195 | |
info:pmid/22336056 |